Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sollers launched a full cycle of production of Sollers Argo trucks

9/7/23 SVAV

NLMK sold its long product division

9/7/23 NLMK

Fix Price plans to enter the UAE market in 2024

9/7/23 FIXP

Ozon opens a new logistics complex in the Moscow region

9/7/23 OZON

Yandex and Xiaomi released the first joint device

9/7/23 YNDX

Fix Price retail revenue in the first half of the year grew by 2.9%

9/7/23 FIXP

Fix Price has reported for 6 months of 2023

9/7/23 FIXP

Fesco considers plans to build up its fleet in the Baltic Sea

9/7/23 FESH

Gazprom will not buy out the additional issue of OGK-2

9/7/23 OGKB

Moscow Exchange plans to connect to all DFA issuance platforms

9/6/23 MOEX